HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicolas Giroud Selected Research

cibisatamab

1/2016Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCB.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicolas Giroud Research Topics

Disease

2Neoplasms (Cancer)
01/2016 - 05/2015
1Retinal Degeneration
08/2021
1Geographic Atrophy
08/2021
1Atrophy
08/2021
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
11/2017
1Circulating Neoplastic Cells
05/2015
1Triple Negative Breast Neoplasms
05/2015

Drug/Important Bio-Agent (IBA)

2Biological ProductsIBA
01/2016 - 05/2015
1sodium iodateIBA
08/2021
1Complement System Proteins (Complement)IBA
08/2021
1ChemokinesIBA
08/2021
1CytokinesIBA
08/2021
1Retinaldehyde (Retinal)IBA
08/2021
1cibisatamabIBA
01/2016
1Carcinoembryonic AntigenIBA
01/2016
1Tumor Biomarkers (Tumor Markers)IBA
05/2015
1Biomarkers (Surrogate Marker)IBA
05/2015
1DNA (Deoxyribonucleic Acid)IBA
05/2015
1Circulating Tumor DNAIBA
05/2015

Therapy/Procedure

2Therapeutics
08/2021 - 11/2017